|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 26.21 USD | +0.15% |
|
+0.65% | +5.26% |
| 12:18pm | Drugmakers will not be exempt from cost cuts, says German health minister | RE |
| 05:23am | After Euphoria, a Traffic Jam on the Multi-Billion Dollar Kilo-Highway |  |
| Market Cap | 149B 129B 119B 111B 208B 14,177B 211B 1,402B 547B 6,901B 560B 548B 23,893B | P/E Ratio 2026 * |
12.2x | P/E Ratio 2027 * | 13x |
|---|---|---|---|---|---|
| Enterprise Value | 197B 171B 157B 147B 276B 18,766B 280B 1,855B 723B 9,134B 741B 725B 31,627B | EV / Sales 2026 * |
3.2x | EV / Sales 2027 * | 3.22x |
| Free-Float |
59.05% | Yield 2026 * |
6.7% | Yield 2027 * | 6.67% |
Last Transcript: Pfizer Inc.
| 1 day | +0.02% | ||
| 1 week | +0.40% | ||
| Current month | -0.13% | ||
| 1 month | +1.06% | ||
| 3 months | -2.66% | ||
| 6 months | +1.14% | ||
| Current year | +5.00% |
| 1 week | 25.47 |  | 26.49 |
| 1 month | 25.19 | | 26.54 |
| Current year | 24.83 | | 28.74 |
| 1 year | 23.11 | | 28.74 |
| 3 years | 20.92 | | 40.36 |
| 5 years | 20.92 | | 61.71 |
| 10 years | 20.92 | | 61.71 |
| Manager | Title | Age | Since |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 64 | 2018-12-31 |
David Denton
DFI | Director of Finance/CFO | 61 | 2022-05-01 |
| Chief Tech/Sci/R&D Officer | - | 2006-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Suzanne Johnson
BRD | Director/Board Member | 68 | 2007-08-31 |
Shantanu Narayen
BRD | Director/Board Member | 62 | 2013-09-26 |
Albert Bourla
CHM | Chairman | 64 | 2019-12-31 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| Jun. 08 | Sell | Controller/Auditor | -2,000 | 0.0000% | ||
| May. 28 | Free | Chief Executive Officer | 23 | 0.0000% | ||
| May. 14 | Free | Chief Executive Officer | 24 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.02% | +0.40% | +5.25% | -34.47% | 149B | |
| -1.77% | +0.78% | +40.41% | +156.04% | 1,035B | |
| +0.97% | +3.35% | +53.56% | +50.45% | 574B | |
| +1.17% | -0.07% | +18.01% | +64.87% | 397B | |
| +0.58% | +0.77% | +21.19% | +15.95% | 324B | |
| -0.85% | -2.86% | +22.05% | +13.80% | 281B | |
| +0.44% | +3.48% | +24.48% | +34.39% | 278B | |
| +1.66% | +5.61% | -44.67% | -47.49% | 193B | |
| -0.10% | +1.06% | +18.84% | +62.53% | 191B | |
| -0.37% | -2.97% | +11.85% | +60.97% | 156B | |
| Average | +0.20% | +1.70% | +17.10% | +37.70% | 357.91B | |
| Weighted average by Cap. | -0.10% | +2.37% | +27.16% | +67.62% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 61.69B 53.28B 49.1B 45.96B 86.13B 5,864B 87.46B 580B 226B 2,854B 232B 227B 9,882B | 59.32B 51.24B 47.22B 44.2B 82.83B 5,639B 84.11B 558B 217B 2,745B 223B 218B 9,503B |
| Net income | 11.07B 9.56B 8.81B 8.25B 15.46B 1,052B 15.7B 104B 40.56B 512B 41.55B 40.66B 1,773B | 10.96B 9.47B 8.72B 8.17B 15.3B 1,042B 15.54B 103B 40.16B 507B 41.13B 40.26B 1,756B |
| Net Debt | 48.28B 41.7B 38.42B 35.97B 67.4B 4,589B 68.45B 454B 177B 2,234B 181B 177B 7,733B | 42.08B 36.34B 33.49B 31.35B 58.75B 3,999B 59.66B 395B 154B 1,947B 158B 155B 6,740B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-12 | 26.21 $ | +0.15% | 38,528,031 |
| 26-06-11 | 26.17 $ | +2.23% | 45,268,705 |
| 26-06-10 | 25.60 $ | -0.39% | 30,376,260 |
| 26-06-09 | 25.70 $ | +0.31% | 35,273,222 |
| 26-06-08 | 25.62 $ | -1.61% | 42,028,801 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- PFE Stock
Select your edition
All financial news and data tailored to specific country editions
